Induced myeloid leukemia cell differentiation protein fabcomplex in complex with compound 1 Deposition Author(s): Hargreaves, D.
Date: 2022-08-26 Method: X-RAY DIFFRACTION Resolution: 1.99 Å Organism(s): Homo Sapiens , Mus Musculus Sequences Data: 8AV9_A , 8AV9_H , 8AV9_L
Discovery and optimisation of potent, efficacious and selective inhibitors targeting egfr exon20 insertion mutations. compound 16 bound to egfr Deposition Author(s): Hargreaves, D.
Date: 2023-07-03 Method: X-RAY DIFFRACTION Resolution: 2.51 Å Organism(s): Homo Sapiens Sequences Data: 8PNZ_A
Discovery and optimisation of potent, efficacious and selective inhibitors targeting egfr exon20 insertion mutations. compound 12 bound to egfrinsnpg Deposition Author(s): Hargreaves, D.
Date: 2023-07-03 Method: X-RAY DIFFRACTION Resolution: 2.523 Å Organism(s): Homo Sapiens Sequences Data: 8PO0_A
Discovery and optimisation of potent, efficacious and selective inhibitors targeting egfr exon20 insertion mutations. compound 22 bound to egfrinsnpg [v948r] Deposition Author(s): Hargreaves, D.
Date: 2023-07-03 Method: X-RAY DIFFRACTION Resolution: 2.11 Å Organism(s): Homo Sapiens Sequences Data: 8PO1_A
Discovery and optimisation of potent, efficacious and selective inhibitors targeting egfr exon20 insertion mutations. compound 33 bound to egfrinsnpg [v948r] Deposition Author(s): Hargreaves, D.
Date: 2023-07-03 Method: X-RAY DIFFRACTION Resolution: 2.28 Å Organism(s): Homo Sapiens Sequences Data: 8PO2_A , 8PO2_B , 8PO2_D
Discovery and optimisation of potent, efficacious and selective inhibitors targeting egfr exon20 insertion mutations. compound 18 bound to egfr[v948r] Deposition Author(s): Hargreaves, D.
Date: 2023-07-03 Method: X-RAY DIFFRACTION Resolution: 2.13 Å Organism(s): Homo Sapiens Sequences Data: 8PO3_A
Discovery and optimisation of potent, efficacious and selective inhibitors targeting egfr exon20 insertion mutations. compound 33 bound to egfr[v948r] Deposition Author(s): Hargreaves, D.
Date: 2023-07-03 Method: X-RAY DIFFRACTION Resolution: 1.621 Å Organism(s): Homo Sapiens Sequences Data: 8PO4_A , 8PO4_B
Bfl1 in complex with a reversible covalent ligand Deposition Author(s): Hargreaves, D.
Date: 2024-01-16 Method: X-RAY DIFFRACTION Resolution: 1.791 Å Organism(s): Homo Sapiens Sequences Data: 8RPO_A
Discovery of a series of covalent, cell active bfl-1 inhibitors Deposition Author(s): Hargreaves, D.
Date: 2024-04-03 Method: X-RAY DIFFRACTION Resolution: 1.488 Å Organism(s): Homo Sapiens Sequences Data: 9EW8_A
Optimisation of potent, efficacious, selective and blood-brain barrier penetrating inhibitors targeting egfr exon20 insertion mutations Deposition Author(s): Hargreaves, D.
Date: 2024-04-04 Method: X-RAY DIFFRACTION Resolution: 2.435 Å Organism(s): Homo Sapiens Sequences Data: 9EWS_A